ArticleRenal failure2026
Kidney transplantation in sub-Sahara African countries: challenges and lessons from the experience of Cameroon: a preliminary report of the first 17 pioneer cases.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report presents the outcomes, challenges, and lessons learned from the first 17 cases of kidney transplantation (KT) performed in Cameroon and the Central Africa sub-region. All patients who underwent kidney transplantation at the Yaoundé General Hospital (YGH) are included in this study. Seventeen kidney transplants were performed, nine females and eight males. All donors were family members. The underlying nephropathies were chronic glomerulonephritis (9 cases), hypertensive nephropathy (6 cases), and Unknown origin (4 cases). Immunological compatibility was categorized as follows: HLA-identical (7 pairs), HLA-different (3 pairs), haploidentical (6 pairs), homozygous twin sisters (1 pair) and HLA semi-identical (1 pair). After transplantation, two recipients experienced complications due to an incorrect ureteral implantation into the peritoneum (1 case), and an anastomotic leak (hematoma), another case. All our patients are currently alive, with good quality of life and stable renal function. The treatment protocol was by induction therapy; basiliximab (20 mg on days 0 and 4) or Thymoglobulin, combined with methylprednisolone while maintenance therapy included mycophenolic acid, cyclosporine or tacrolimus, and prednisone. The total cost of patient management, including immune compatibility testing for the first patients, was covered by YGH and its partners. In conclusion, kidney transplantation is a safe and effective treatment in Cameroon. The team at YGH, along with international collaborators, have successfully acquired the necessary technology, and expertise, to perform kidney transplantation, making it a viable option for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.